The future of multiple sclerosis treatment is being shaped by a strong shift toward noninvasive, accessible options, placing oral multiple sclerosis drugs at the forefront of therapeutic and commercial strategies
ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders
Vin ung khng ch gip da c ti to t bn trong, gip da duy tr c s tr trung, trng sng m cn gip bo v gan v mang n nhiu li ch cho tim mch, Astaxanthin c chng minh l c c tnh chng vim, iu chnh min dch v sa cha DNA, iu ny khuyn khch hn na vic s dng n duy tr sc khe ca da v khc phc tn thng da
7 Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025
Retrieved January 21, 2026 via X (formerly Twitter)
Tessema M, Gunaratna NS, Brouwer ID, Donato K, Cohen JL, McConnell M, Belachew T, Belayneh D, De Groote H